Postmenopausal osteoporosis: Etiology, current diagnostic strategies, and nonprescription interventions

Journal of Managed Care Pharmacy

Volumn 12, Issue 6 SUPPL., 2006, Pages

  Kamel, Hosam K ^a  

^a St Joseph's Mercy Health Center Hot Springs   (United States)

Author keywords

Bone; Calcium; Estrogen; Postmenopausal osteoporosis

Indexed keywords

CALCIUM; CALCIUM CARBONATE; VITAMIN D; CAFFEINE; CYTOKINE; ESTROGEN; NON PRESCRIPTION DRUG;

BONE DENSITY; BONE MASS; CALCIUM INTAKE; CLINICAL TRIAL; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; EXERCISE; FRACTURE; HUMAN; LABORATORY TEST; LIFESTYLE MODIFICATION; NORTH AMERICA; NUTRITIONAL ASSESSMENT; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; UNITED STATES; UPREGULATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; AGED; ARTICLE; DRINKING BEHAVIOR; FEMALE; RADIODENSITOMETRY;

AGED; ALCOHOL DRINKING; BONE DENSITY; BONE RESORPTION; CAFFEINE; CALCIUM, DIETARY; CYTOKINES; DENSITOMETRY, X-RAY; DRUGS, NON-PRESCRIPTION; ESTROGENS; EXERCISE; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SMOKING CESSATION; UP-REGULATION; VITAMIN D;

EID: 34247587314     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.s6-a.s4     Document Type: Review

References (31)

1. Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med. 1986;314:1676-86.
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95. Available at: http://consensus.nih.gov/2000/ 2000Osteoporosis111html.htm. Accessed April 19, 2006.
3. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/professionals/ clinical.htm. Accessed April 19, 2006.
4. Hodgson SF, Watts NB, Bilezikian JP, et al. for the AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9:544-64.
5. O'Connell MB, Seaton TL. Osteoporosis and osteomalacia. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York, NY: McGraw-Hill; 2005:1645-69.
6. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-22.
7. North American Menopause Society. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause. 2002;9:84-101.
8. Hannan MT, Felson DT, Dawson-Hughes B, et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000;15:710-20.
9. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-73.
10. Medicare program; Medicare coverage of and payment for bone mass measurements - HCFA. Interim final rule with comment period. Fed Regist. 1998;63(121):34320-28.
11. Lindsay R, Cosman F. Osteoporosis. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:2268-78.
12. Dogan E, Posaci C. Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women. Postgrad Med J. 2002;78:727-31.
13. Bonnick SL, Shulman. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med. 2006;119(4 suppl 1):S25-S31.
14. Shea B, Wells G, Cranney A, et al. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev. 2004;(1):CD004526.
15. Looker AC, Harris TB, Madans JH, Sempos CT. Dietary calcium and hip fracture risk: the NHANES I Epidemiologic Follow-Up Study. Osteoporos Int. 1993;3:177-84.
16. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fractures and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;1666(8):869-75.
17. National Academy of Sciences. Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride. Available at: http://fermat.nap.edu/html/dri_calcium/tables.html. Accessed April 19, 2006.
18. U.S. Department of Agriculture. USDA national nutrient database for standard reference, release 17: calcium, ca (mg) content of selected foods per common measure, sorted by nutrient content. Available at: http://www.nal.usda. gov/fnic/foodcomp/Data/SR17/wtrank/sr17w301.pdf. Accessed April 19, 2006.
19. McEvoy GK, ed. Calcium salts. In: AHFS Drug Information 2006. Bethesda, MD: American Society of Health-System Pharmacists; 2006:2601-07.
20. Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporos Int. 2000;11:553-55.
21. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-10.
22. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2005;(3):CD000227.
23. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637-42.
24. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-76.
25. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669-83.
26. Bischoff-Ferrari HA, Dawson-Hughes B, Willet WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006.
27. Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33:589-95.
28. van Driel M, Pols HA,Van Leeuwen JP. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des. 2004;10:2535-55.
29. Dechant KL, Goa KL. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis. Drugs Aging. 1994;5:300-17.
30. Coburn JW, Tan AU Jr, Levine BS, et al. 1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compound. Nephrol Dial Transplant. 1996;11(suppl 3):153-57.
31. U.S. Department of Health and Human Services. Chapter 9: Prevention and treatment for those who have bone diseases. In: Bone Health and Osteoporosis: A Report of the Surgeon General (2004). Available at: http://www. surgeongeneral.gov/library/bonehealth/chapter_9.html#PhysicalActivity. Accessed April 26, 2006.